Page 651 - Williams Hematology ( PDFDrive )

626 Part VI: The Erythrocyte <CN>: <ct> PB

56. Pak M, Lopez MA, Gabayan V, et al: Suppression of hepcidin during anemia requires 94. Feder JN, Gnirke A, Thomas W, et al: A novel MHC class I-like gene is mutated in
erythropoietic activity. Blood 108:3730, 2006. patients with hereditary haemochromatosis. Nat Genet 13:399, 1996.
57. Ganz T, Olbina G, Girelli D, et al: Immunoassay for human serum hepcidin. Blood 95. Zhou XY, Tomatsu S, Fleming RE, et al: HFE gene knockout produces mouse model of
112:4292, 2008. hereditary hemochromatosis. Proc Natl Acad Sci U S A 95:2492, 1998.
58. Ramos E, Kautz L, Rodriguez R, et al: Evidence for distinct pathways of hepcidin regu- 96. Ahmad KA, Ahmann JR, Migas MC, et al: Decreased Liver Hepcidin Expression in the
lation by acute and chronic iron loading in mice. Hepatology 53:1333, 2011. Hfe Knockout Mouse. Blood Cells Mol Dis 29:361, 2002.
59. Corradini E, Meynard D, Wu Q, et al: Serum and liver iron differently regulate the 97. Montosi G, Donovan A, Totaro A, et al: Autosomal-dominant hemochromatosis is
bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619,
54:273, 2011. 2001.
60. Lin L, Valore EV, Nemeth E, et al: Iron transferrin regulates hepcidin synthesis in 98. Zohn IE, De Domenico I, Pollock A, et al: The flatiron mutation in mouse ferroportin
primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110:2182, 2007. acts as a dominant negative to cause ferroportin disease. Blood 109:4174, 2007.
61. Schmidt PJ, Toran PT, Giannetti AM, et al: The transferrin receptor modulates Hfe- 99. Njajou OT, Vaessen N, Joosse M, et al: A mutation in SLC11A3 is associated with auto-
dependent regulation of hepcidin expression. Cell Metab 7:205, 2008. somal dominant hemochromatosis. Nat Genet 28:213, 2001.
62. Schmidt PJ, Huang FW, Wrighting DM, et al: Hepcidin expression is regulated by a com- 100. Sham RL, Phatak PD, Nemeth E, et al: Hereditary hemochromatosis due to resistance to
plex of hemochromatosis-associated proteins. ASH Annu Meet Abstr 108:267, 2006. hepcidin: High hepcidin concentrations in a family with C326S ferroportin mutation.
63. D’Alessio F, Hentze MW, Muckenthaler MU: The hemochromatosis proteins HFE, Blood 114:493, 2009.
TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. 101. Altamura S, Groene HJ, Kessler R, et al: In vivo disruption of the hepcidin-ferroportin reg-
J Hepatol 57:1052, 2012. ulatory circuitry causes fatal systemic and exocrine pancreatic iron overload [abstract].
64. Rishi G, Crampton EM, Wallace DF, et al: In situ proximity ligation assays indicate that ASH Annu Meet Abstr 175, 2013.
hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact. PLoS 102. De Sousa M, Reimao R, Lacerda R, et al: Iron overload in beta 2-microglobulin-deficient
One 8:e77267, 2013. mice. Immunol Lett 39:105, 1994.
65. Papanikolaou G, Samuels ME, Ludwig EH, et al: Mutations in HFE2 cause iron over- 103. Rothenberg BE, Voland JR: Beta2 knockout mice develop parenchymal iron overload:
load in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77, 2004. A putative role for class I genes of the major histocompatibility complex in iron metab-
66. Babitt JL, Huang FW, Wrighting DM, et al: Bone morphogenetic protein signaling by olism. Proc Natl Acad Sci U S A 93:1529, 1996.
hemojuvelin regulates hepcidin expression. Nat Genet 38:531, 2006. 104. Goya N, Miyazaki S, Kodate S, et al: A family of congenital atransferrinemia. Blood
67. Lin L, Nemeth E, Goodnough JB, et al: Soluble hemojuvelin is released by proprotein 40:239, 1972.
convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol Dis 105. Bernstein SE: Hereditary hypotransferrinemia with hemosiderosis, a murine disorder
40:122, 2008. resembling human atransferrinemia. J Lab Clin Med 110:690, 1987.
68. Lin L, Goldberg YP, Ganz T: Competitive regulation of hepcidin mRNA by soluble and 106. Hamill RL, Woods JC, Cook BA: Congenital atransferrinemia. A case report and review
cell-associated hemojuvelin. Blood 106:2884, 2005. of the literature. Am J Clin Pathol 96:215, 1991.
69. Truksa J, Lee P, Beutler E: Two BMP responsive elements, STAT, and bZIP/HNF4/ 107. Trenor CC, III, Campagna DR, Sellers VM, et al: The molecular defect in hypotransfer-
COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV respon- rinemic mice. Blood 96:1113, 2000.
siveness. Blood 113:688, 2009. 108. Bartnikas TB, Andrews NC, Fleming MD: Transferrin is a major determinant of hep-
70. Silvestri L, Pagani A, Nai A, et al: The serine protease matriptase-2 (TMPRSS6) inhibits cidin expression in hypotransferrinemic mice. Blood 117:630, 2011.
hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 8:502, 2008. 109. Levy JE, Jin O, Fujiwara Y, et al: Transferrin receptor is necessary for development of
71. Truksa J, Gelbart T, Peng H, et al: Suppression of the hepcidin-encoding gene Hamp erythrocytes and the nervous system. Nat Genet 21:396, 1999.
permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. 110. Camaschella C, Roetto A, Cali A, et al: The gene TFR2 is mutated in a new type of
Br J Haematol 147:571, 2009. haemochromatosis mapping to 7q22. Nat Genet 25:14, 2000.
72. Du X, She E, Gelbart T, et al: The serine protease TMPRSS6 is required to sense iron 111. Fleming RE, Ahmann JR, Migas MC, et al: Targeted mutagenesis of the murine trans-
deficiency. Science 320:1088, 2008. ferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A 99:10653,
73. Finch C: Regulators of iron balance in humans. Blood 84:1697, 1994. 2002.
74. Kautz L, Jung G, Valore EV, et al: Identification of erythroferrone as an erythroid regu- 112. Harris ZL, Takahashi Y, Miyajima H, et al: Aceruloplasminemia: Molecular characteri-
lator of iron metabolism. Nat Genet 2014. zation of this disorder of iron metabolism. Proc Natl Acad Sci U S A 92:2539, 1995.
75. Tanno T, Bhanu NV, Oneal PA, et al: High levels of GDF15 in thalassemia suppress 113. Kato J, Fujikawa K, Kanda M, et al: A mutation, in the iron-responsive element of H fer-
expression of the iron regulatory protein hepcidin. Nat Med 13:1096, 2007. ritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 69:191, 2001.
76. Drakesmith H, Prentice AM: Hepcidin and the iron-infection axis. Science 338:768, 2012. 114. Iolascon A, De FL: Mutations in the gene encoding DMT1: Clinical presentation and
77. Wrighting DM, Andrews NC: Interleukin-6 induces hepcidin expression through treatment. Semin Hematol 46:358, 2009.
STAT3. Blood 108:3204, 2006. 115. Blanco E, Kannengiesser C, Grandchamp B, et al: Not all DMT1 mutations lead to iron
78. Pietrangelo A, Dierssen U, Valli L, et al: STAT3 is required for IL-6-gp130-dependent overload. Blood Cells Mol Dis 43:199, 2009.
activation of hepcidin in vivo. Gastroenterology 132:294, 2007. 116. Fleming MD, Trenor CC, III, Su MA, et al: Microcytic anaemia mice have a mutation in
79. Verga Falzacappa MV, Vujic SM, Kessler R, et al: STAT3 mediates hepatic hepcidin Nramp2, a candidate iron transporter gene. Nat Genet 16:383, 1997.
expression and its inflammatory stimulation. Blood 109:353, 2007. 117. Fleming MD, Romano MA, Su MA, et al: Nramp2 is mutated in the anemic Belgrade
80. Besson-Fournier C, Latour C, Kautz L, et al: Induction of activin B by inflamma- (b) rat: Evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci
tory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through U S A 95:1148, 1998.
Smad1/5/8 signaling. Blood 120:431, 2012. 118. Roetto A, Papanikolaou G, Politou M, et al: Mutant antimicrobial peptide hepcidin is
81. Aisen P: Transferrin receptor 1. Int J Biochem Cell Biol 36:2137, 2004. associated with severe juvenile hemochromatosis. Nat Genet 33:21, 2003.
82. Muckenthaler MU, Galy B, Hentze MW: Systemic iron homeostasis and the 119. Lesbordes-Brion JC, Viatte L, Bennoun M, et al: Targeted disruption of the hepcidin 1
iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu gene results in severe hemochromatosis. Blood 108:1402, 2006.
Rev Nutr 28:197, 2008. 120. Niederkofler V, Salie R, Arber S: Hemojuvelin is essential for dietary iron sensing, and
83. Rouault TA: The role of iron regulatory proteins in mammalian iron homeostasis and its mutation leads to severe iron overload. J Clin Invest 115:2180, 2005.
disease. Nat Chem Biol 2:406, 2006. 121. Huang FW, Pinkus JL, Pinkus GS, et al: A mouse model of juvenile hemochromatosis.
84. Nemeth E, Roetto A, Garozzo G, et al: Hepcidin is decreased in TFR2 hemochromato- J Clin Invest 115:2187, 2005.
sis. Blood 105:1803, 2005. 122. Meynard D, Kautz L, Darnaud V, et al: Lack of the bone morphogenetic protein BMP6
85. Silvestri L, Nai A, Pagani A, et al: The extrahepatic role of TFR2 in iron homeostasis. induces massive iron overload. Nat Genet 41:478, 2009.
Front Pharmacol 5:93, 2014. 123. Andriopoulos B Jr, Corradini E, Xia Y, et al: BMP6 is a key endogenous regulator of
86. Vashisht AA, Zumbrennen KB, Huang X, et al: Control of iron homeostasis by an hepcidin expression and iron metabolism. Nat Genet 41:482, 2009.
iron-regulated ubiquitin ligase. Science 326:718, 2009. 124. Steinbicker AU, Bartnikas TB, Lohmeyer LK, et al: Perturbation of hepcidin expression
87. Salahudeen AA, Thompson JW, Ruiz JC, et al: An E3 ligase possessing an iron-responsive by BMP type I receptor deletion induces iron overload in mice. Blood 118:4224, 2011.
hemerythrin domain is a regulator of iron homeostasis. Science 326:722, 2009. 125. Wang RH, Li C, Xu X, et al: A role of SMAD4 in iron metabolism through the positive
88. Chen W, Dailey HA, Paw BH: Ferrochelatase forms an oligomeric complex with regulation of hepcidin expression. Cell Metab 2:399, 2005.
mitoferrin-1 and Abcb10 for erythroid heme biosynthesis. Blood 116:628, 2010. 126. Lee DH, Zhou LJ, Zhou Z, et al: Neogenin inhibits HJV secretion and regulates BMP-
89. Sheftel AD, Zhang AS, Brown C, et al: Direct interorganellar transfer of iron from endo- induced hepcidin expression and iron homeostasis. Blood 115:3136, 2010.
some to mitochondrion. Blood 110:125, 2007. 127. Enns CA, Ahmed R, Zhang AS: Neogenin interacts with matriptase-2 to facilitate
90. Cartwright GE, Deiss A: Sideroblasts, siderocytes, and sideroblastic anemia. N Engl J hemojuvelin cleavage. J Biol Chem 287:35104, 2012.
Med 292:185, 1975. 128. Mackenzie B, Garrick MD: Iron Imports. II. Iron uptake at the apical membrane in the
91. Levi S, Arosio P: Mitochondrial ferritin. Int J Biochem Cell Biol 36:1887, 2004. intestine. Am J Physiol Gastrointest Liver Physiol 289:G981, 2005.
92. Cazzola M, Invernizzi R, Bergamaschi G, et al: Mitochondrial ferritin expression in 129. Smith MD, Pannacciulli IM: Absorption of inorganic iron from graded doses: Its sig-
erythroid cells from patients with sideroblastic anemia. Blood 101:1996, 2003. nificance in relation to iron absorption tests and mucosal block theory. Br J Haematol
93. Green R, Charlton R, Seftel H, et al: Body iron excretion in man: A collaborative study. 4:428, 1958.
Am J Med 45:336, 1968. 130. McKie AT: A ferrireductase fills the gap in the transferrin cycle. Nat Genet 37:1159, 2005.

Kaushansky_chapter 42_p0617-0626.indd 626 9/17/15 6:26 PM